Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification.
Saved in:
| Title: | Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification. |
|---|---|
| Authors: | Mazzotta, M.1, Filetti, M.1, Rossi, A.1, Roberto, M.1, Occhipinti, M.2, Pernazza, A.3, Di Napoli, A.4, Scarpino, S.4, Vecchione, A.4, Giusti, R.1 rgiusti@ospedalesantandrea.it, Marchetti, P.1,2 |
| Source: | Annals of Oncology. Mar2020, Vol. 31 Issue 3, p440-441. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2019.11.016 |
